Summary
In a 12-month double-blind placebo-controlled trial, the effect of sulphasalazine was studied in 40 patients with ankylosing spondylitis. The treatment group showed significant improvement in pain, stiffness, sleep disturbance (p<0.05), finger/floor distance, erythrocyte sedimentation rate, C-reactive protein, orosomucoid and IgA levels (p<0.01). There was improvement in sleep disturbance (p<0.05), finger/floor distance and erythrocyte sedimentation rate (p<0.01) in the placebo group. Sulphasalazine did not retard radiological progression as measured either by plain X-ray or computerised tomographic scans. Multiple analysis of variance did not show a significant difference in disease activity indicators between the 2 groups.
Similar content being viewed by others
References
Feltelius, N., Hallgren, R. Sulphasalazine in ankylosing spondylitis. Ann Rheum Dis 1986, 45, 396–399.
Dougados, M., Boumier, P., Amor, B. Sulphasalazine in ankylosing spondylitis: a double-blind controlled study in 60 patients. Br Med J 1986, 293, 911–914.
Nissila, M., Lehtinen, K., Leirisalo-Repo, M., Luukhainen, R., Mutru, O., Yli-Kerttula, U. Sulphasalazine in the treatment of ankylosing spondylitis. Arthritis Rheum 1988, 31, 1111–1116.
Hepburn, B. What is a disease modifying antirheumatic drug? J Rheumatol 1988, 15 (Supp 16), 40–42.
Hyde, S. Physiotherapy in Rheumatology. Oxford, Blackwell Scientific Publications, 1980, 121–122.
McConkey, B., Amos, R.S., Butler, E.P., Crockson, R.A., Crockson, A.P., Walsh, L. Salazopyrin in rheumatoid arthritis. Agents Actions 1978, 8, 438–441.
Wardle, T., Beswick, E.J., Dawes, P.T. Scoring radiological damage in ankylosing spondylitis (AS) — analysis of the X-ray score and clinical/laboratory variables. Br J Rheumatol 1988, 27 (Supp 1), 547.
Pullar, T., Hunter, J.A., Capell, H.A. Sulphasalazine in rheumatoid arthritis: a double-blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J 1983, 287, 1102–1104.
Pinals, R.S., Kaplan, S.B., Lawson, J.G., Hepburn, B. Sulphasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 1986, 29, 1427–34.
Editorial. Assessing disease activity in ankylosing spondylitis. Lancet 1987, i, 1072.
Nashel, D.J., Petrone, D.L., Ulmer, C.C., Sliwinski, A.J., C-reactive protein: a marker for disease activity in ankylosing spondylitis and Reiter's Syndrome. J Rheumatol 1986, 13, 2, 364–367.
Cowling, P., Ebringer, R., Cawdell, D., Ishii, M., Ebringer, A. C-reactive protein, ESR and klebsiella in ankylosing spondylitis. Ann Rheum Dis 1980, 39, 45–49.
Sheeham, N.J., Slavin, B.M., Donovan, M.P., Mount, J.N., Nathews, J.A. Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 1986, 25, 171–174.
Laurent, M.R., Panayi, G.S. Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 1983, 42, 524–528.
Cowling, P., Ebringer, R., Ebringer, A. Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann Rheum Dis 1980, 39, 545–549.
Franssen, M.J.A.M., van de Putte, L.B.A., Gribnau, F.W.J. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study. Ann Rheum Dis 1985, 44, 766–771.
Sanders, K.M., Hertzman, A., Escobar, M.R., Littman, B.H. Correlation of immunoglobulin and C-reactive protein levels in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 1987, 46, 273–276.
Mielants, H., Veys, E.M., Joos, R. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis. Clin Rheumatol 1986, 5, 80–83.
McGuigan, L.E., Prendergast, J.K., Geczy, A.F., Edmonds, J.P., Bashir, H.V. Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis. Ann Rheum Dis 1986, 45, 566–571.
Ebringer, R.W., Cawdell, D.R., Cowling, P., Ebringer, A. Sequential studies in ankylosing spondylitis. Association of klebsiella pneumoniae with active disease. Ann Rheum Dis 1978, 37, 146–151.
Pease, P.E., Balmer, S.E., Tallack, J.E., et al. Further observations upon HLA-B27, Yersinia enterocolitica and ankylosing spondylitis. Ann Rheum Dis 1986, 45, 526–528.
Trull, A.K., Ebringer, A., Panayi, G., Ebringer, R., James, D.C.O. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol 1984, 551, 74–80.
Andreason, J.J., Andersen, L.P., Hartgen, S.H. In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5 aminosalicylic acid, sulfapyridine and four quinolones. APMIS 1988, 96, 568–570.
Boersma, J.W. Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. Scand J Rheumatol 1976, 5, 60–64.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taylor, H.G., Beswick, E.J. & Dawes, P.T. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment. Clin Rheumatol 10, 43–48 (1991). https://doi.org/10.1007/BF02208032
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02208032